EP2907535B1 - Syringe type pump - Google Patents
Syringe type pump Download PDFInfo
- Publication number
- EP2907535B1 EP2907535B1 EP15154808.8A EP15154808A EP2907535B1 EP 2907535 B1 EP2907535 B1 EP 2907535B1 EP 15154808 A EP15154808 A EP 15154808A EP 2907535 B1 EP2907535 B1 EP 2907535B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- base plate
- skin
- cannula
- patient
- barrel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012530 fluid Substances 0.000 claims description 27
- 230000007246 mechanism Effects 0.000 claims description 21
- 239000012790 adhesive layer Substances 0.000 claims description 13
- 238000003825 pressing Methods 0.000 claims description 4
- 238000010254 subcutaneous injection Methods 0.000 claims description 2
- 239000007929 subcutaneous injection Substances 0.000 claims description 2
- 239000007924 injection Substances 0.000 description 28
- 238000002347 injection Methods 0.000 description 28
- 238000004458 analytical method Methods 0.000 description 12
- 239000000523 sample Substances 0.000 description 9
- 241001631457 Cannula Species 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 238000010276 construction Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 3
- 210000003722 extracellular fluid Anatomy 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 238000001690 micro-dialysis Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 230000011218 segmentation Effects 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910010293 ceramic material Inorganic materials 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 1
- 235000020938 metabolic status Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
- A61M5/14216—Reciprocating piston type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150229—Pumps for assisting the blood sampling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
- A61M5/1454—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons spring-actuated, e.g. by a clockwork
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3287—Accessories for bringing the needle into the body; Automatic needle insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
- A61M2005/14252—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
- A61M2005/31518—Piston or piston-rod constructions, e.g. connection of piston with piston-rod designed to reduce the overall size of an injection device, e.g. using flexible or pivotally connected chain-like rod members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
Definitions
- the present invention is related with a device for subcutaneous injection according to the preamble of claim 1.
- One major field of application for this type of device is the injection of physiologically active fluid into a patient and/or the extraction of body fluid for diagnostic purposes.
- the devices are usually equipped with both a contact surface for attaching to a patient's skin and a cannula for the access to the patient's tissue or vessels for introducing an injection fluid or the removal of analysis fluid.
- Injection devices are widely used in patient care but their size and complexity largely restricts their use to specialized facilities. Recently, ambulatory use of injection devices has been pioneered in diabetes care for the delivery of insulin.
- Wearable drug delivery devices with needles or cannulas and base or bottom members provided with adhesive layers for attachment to a patient's skin are known.
- the base members are shaped such that they project beyond the cannula tips.
- drug delivery the devices are attached to patients and the cannulas are inserted into the skin.
- Document US 5,931,814 discloses a dermally affixed injection device with a base plate in the form of a cup spring which is provided with an annular adhesive layer for attachment to a patient. Prior to use the base plate is bent to a prestressed shape in which it projects beyond the cannula tip for protecting the cannula. When the spring is released it snaps into its flat position to allow the skin to move towards the cannula.
- US 2004/0116865 discloses a wearable drug infusion device with a base plate provided with an adhesive layer.
- the base plate has the form of a bistable disc member having a convex and a concave shape. Prior to use the disc member is in its convex shape to protect the needle. To attach the device to a patient and insert the needle the device is manually pressed onto the skin, thereby causing the bistable disc to snap to its concave shape and the needle to be pressed into the skin.
- US 2002/0022798 discloses a wearable drug infusion device with a collapsible bottom cover which prior to use projects beyond the height of the needle. For insertion of the needle into a patient's skin the device is manually pressed onto the skin so that the bottom cover collapses and the needle is pressed into the skin.
- US 2004/0116865 discloses a needle insertion device with a rigid base plate which is adhesively attached to the skin and has a central portion which upon pressure onto the casing snaps inwards and pulls a small region of the skin towards the needle.
- US 2002/022798 discloses a fluid delivery device with a needle which is pressed into the skin by turning a selector knob.
- US 6,186,982 discloses a drug delivery device in which by pressing the casing with a needle towards a hinged base plate whereby the needle pierces the skin.
- US 4,393,870 discloses an injection device with which the patient's skin is sucked against a cannula by use of a vacuum. None of the disclosed insertion mechanisms fulfills all the desired requirements, such as painless skin piercing, compatibility with patch-type devices or reliability of skin piercing.
- the aim of the present invention is to provide an injection device with an improved insertion method which avoids the disadvantages of the state of the art devices.
- the device has a contact surface for contacting a patient's skin or an intravenous port.
- the contact surface to the skin is coated with an adhesive and the syringe pump is linked to a cannula having a tip which is configured and dimensioned for piercing the patient's skin or a septum of a port and introducing an injection fluid into the patient or removing analysis fluid.
- the inventive device has a cannula which is fixedly positioned relative to a casing and to the syringe pump.
- the insertion mechanism of the cannula into the patient's skin comprises preferably a flexible contact surface adhering to the skin.
- Adhesive contact surface for temporary wearing on the skin is made of materials with strong adhesive properties, stretchability and minimal allergenicity.
- This adhesive layer is fixed on the base of the device either covering the entire surface or at least its central part leaving a free rim in such a way that it does not interfere with its flexibility.
- the surface of the adhesive layer which is fixed to the skin is significantly larger than its surface which is fixed to the flexible base of the device, leaving a rim which is not fixed to the flexible base. This can be accomplished e.g.
- Analysis fluid is blood, interstitial fluid or dialysate having been in contact with interstitial fluid through a semi-permeable membrane.
- Analyte means any endogenous or exogenous substance the concentration of which can be used to diagnose the health, organ function, metabolic status, or drug metabolizing capacity of an individual.
- endogenous substances are glucose, lactate, oxygen, creatinine, etc.
- exogenous substances are drugs, metabolites of such drugs, diagnostic substances (e.g. inulin) etc.
- Component with a flexible surface is made up of a casing which has preferentially a circular or oval footprint and which has a flexible base.
- This base plate is constructed in such a way that it can be deformed to a convex shape with a protruding part e.g. like a cone or a gable (position 1).
- An additional feature of this base is that it can shoot from the convex shape into a flat shape (position 2) with sufficient velocity and force that this movement can provide the driving energy for implantation of the implantable parts of injection cannulas or diagnostic probes by pulling the skin attached by the adhesive surface against the tip of the cannulas or diagnostic probes.
- Such a flexible surface can be achieved by appropriate segmentation of the surface with hinge regions acting as springs and/or by using elastic materials with the necessary reversible stretching characteristics which moves e.g. from a pre-stressed shape to adopt a flat, relaxed shape.
- Means to position the flexible surface relative to the the implantable parts of injection cannulas or diagnostic probes in two defined positions consists of elements which can bring about the deformation of the flexible surface to a convex, pre-stressed shape and allow a rapid release from this position to adopt a flat, relaxed shape in a coordinated way for the entire surface. This can be accomplished preferentially by several pin-shaped elements protruding from the flexible surface and pushing onto a sliding bolt mechanism, but other constructions using screws, ramps, levers etc. are also possible.
- Such a component with a flexible surface can be manufactured by injection molding of suitable plastics but also by using other materials like steel, composite or ceramic materials, etc.
- the base of this element has an opening in form of a hole or slit, as opening for the implantable parts of injection cannulas or diagnostic probes.
- the implantable parts of injection cannulas or diagnostic probes are positioned axially to this base in such a way that in position 1 they are entirely covered up, whereas in position 2 they protrude the base.
- injection fluid encompasses both relatively fast injection (bolus) and relatively slow introduction (also called infusion or instillation) of a liquid into the body.
- Diagnostic probe is the functional element for the determination of analyte concentrations and means, but is not restricted to, any analysis fluid removal and on-line analysis or sampling system.
- a dialysis membrane forms the interface between the interstitial fluid and a dialysis fluid which is passed at the other side of the membrane.
- a micro-dialysis probe consists of an outer and an inner barrel, covered at the implantable tip by a dialysis membrane. The inner barrel is connected to the pump which delivers the dialysis fluid and the outer barrel is connected to an analysis or sampling system.
- Functional package is designed to hold the rigid part of the device by a releasable coupling mechanism and has a removable cap to protect the active surface of the diagnostic probes during storage in a defined environment, such as humidity and allows maintaining sterility.
- the functional package has also a rim element allowing, after removal of the cap, the correct attachment of the rim of the adhesive layer by pressing against the skin. Further, the functional package protects the release/start mechanism of the device against premature, unintended operation and the release/start mechanism can be actuated only following attachment of the device to the skin and removal of the functional package.
- Intravenous port comprises a catheter placed into a vein and having a connective element, preferably a septum at the exterior end of the catheter.
- Sampling means is the functional element for collecting samples of analysis fluid for determination of analytes external to the device by, but not limited to biochemical, immunological, HPLC, or LC/MS/MS methods.
- the samples can be collected in separated receptacles or in a continuous cavity, e.g. a barrel or tube taking precautions that mixing of samples taken at different times is reduced to a minimum. This can be achieved e.g. by introduction of segments of air or of a non-miscible fluid into the analysis fluid creating separated samples in the continuous cavity.
- Sliding bolt mechanisms adapts upon a circular or linear movement consecutively several fixed positions and consists of elements which display a closed or open state, for example a solid surface or a hole.
- the movement of the slide mechanism is driven manually or for example by a spring actuated by a release element, for example through pressing or releasing a button or handle, or through a turning movement.
- the injection device shown in Fig. 1 has a casing having a cylindrical side-wall 1 housing a barrel in form of a segment of a toroidal tube 2.
- One end 3 of the barrel is provided with a connecting channel to a cannula (not shown).
- the barrel has a circular cross section.
- a piston 4 is arranged in the interior of the barrel and is provided with a seal fitting tightly at the inner wall of the barrel.
- the piston is connected to a driving rod 6 which is circularly shaped for driving the piston through the entire length of the barrel.
- the driving rod At its end opposite the piston the driving rod has a perpendicularly bent arm 7 extending to a central pivot, thereby reducing the radial component of the force and the resulting friction by moving the piston through the barrel.
- the inner side of the rod has a gear rim 8 which is driven by a gear drive 9.
- the gear drive is driven e.g. by a gear train and an electrical motor (for example a watchwork drive) which can be regulated for controlled delivery by signals from inbuilt and/or remote control elements (not shown in the figure).
- an electrical motor for example a watchwork drive
- other drives as known in prior art, can be employed.
- a difference of only 2% between the radius of the barrel and of the driving rod causes a serious relative shift which can lead to collision between barrel wall and driving rod for torus arcs of e.g. 150° - 160° which can be manufactured with standard technologies and are aimed at in order to sufficiently reduce the footprint of the syringe-type pump.
- the plastics parts usually used to manufacture the housing holding the barrel and the guideways for the driving rod are not absolutely rigid and can slightly deform especially under the applied forces necessary to provide the pressures of several bar to overcome tissue resistance.
- the solution to avoid stick-slip phenomena and/or problems with tightness or even blockage of the piston or clamping between the rigid driving rod and the barrel wall is to use a driving rod of the piston which adapts to the actual curvature of the barrel, being guided and supported by the inner wall of the barrel.
- the rod guided and supported by the inner wall of the barrel of the subject invention can adapt to all deviations from the ideal shape and geometry which are unavoidable using cost-effective manufacturing technologies and materials.
- a preferred embodiment of the subject invention, which can be adapted for both, fluid delivery and fluid withdrawal, is exemplified in Fig 2 .
- Fig. 2 is the central part of a tangential cut of the device through the end portion 3 of the barrel.
- a first channel 15 is leading to the upper side of the device and is closed by a septum 14.
- a syringe (not shown) having a needle 13 is pierced through the septum 14.
- the piston is touching the end portion 3 of the barrel (not shown). The injection fluid is introduced through channel 15, thereby pushing the piston towards the opposite end of the barrel.
- a second channel 17 is leading from the interior of barrel 2 to an injection cannula 16 for delivery of injection fluid into the skin.
- the cannula 16 is closed at the other end with a septum-seal 18 which is held in a housing 19.
- the overall construction is such that the dead volume is minimal and no significant volume of air is in the system after filling with injection fluid.
- the insertion means into the skin of the cannula 16 has a flexible base plate 20 which is attached to the skin by an adhesive layer 21.
- this flexible base plate is deformed to a convex shape covering the cannula 16.
- the base plate is preferentially annular or oval and in order to insert a cannula which is remote from the center of the device consists preferentially of two segments with a diagonal slit, forming a gable upon bending.
- This configuration allows also to use this insertion means for more than one cannula simultaneously which are positioned along the diagonal slit, e.g. if more than one infusion pumps for more than one infusion fluid is used and/or for the combination with insertion of a diagnostic probe into the skin.
- the septum-seal 18 is pierced by the cannula before it enters the skin.
- the segments are attached to the circumference of the casing 1 by springy hinge regions and are in addition preferentially made of a flexible material.
- Alternative forms like a radial segmentation, preferably into 5 to 8 segments with a spacing between them and a central opening, forming a cone upon central bending are also possible if the cannula is placed close to the center of the device.
- the flexible base plate On its underside, the flexible base plate has an annular or oval adhesive layer for securing the device to the patient's skin with a diagonal slit or a concentric central opening, respectively similar to the base plate.
- This adhesive layer is composed of three parts, a glue for fixing to the flexible base plate, a textile providing the necessary flexibility and a glue for fixing onto the skin. Suitable materials with low allergenicity potential are commercially available.
- the adhesive layer can have a larger circumference than the device but it could have also the same circumference if the attachment to the base plate leaves an outer zone where it is not connected to the housing.
- the pre-stressed base plate Upon release of the pre-stressed base plate actuated e.g. by a sliding bolt mechanism (not shown) it rapidly relaxes to a flat shape towards the bottom of the housing of the device 1, pushes the housing 19 of the septum-seal 18, and the cannula 16 pierces through the septum-seal 18 and through the skin attached by the adhesive layer.
- the drive means for moving the piston or the implantation mechanism of the cannula for delivery of injection fluid into a patient, or for removal of analysis fluid of a patient could be achieved via numerous chemical, mechanical, or electrical means.
- a large variety of diagnostic elements for the online analysis or for sampling of analysis fluid for removed analysis as well as control and measuring means can be accommodated with the device.
- the major advantages of a device with a toroidal syringe-type pump described above are its reduced footprint-size by which it can be comfortably worn and operated by the patient and at the same time the inherent high precision of a syringe type pump.
- the intrinsic problems of such pumps exemplified in prior art of sealing, friction causing stick-slip phenomena, and even blockage caused by lack of exact fit between the actual form of the arcuate barrel and of the plunger unavoidable in manufacturing of the toroidal barrel and the device using standard cost-effective technologies are solved by using as the drive for the piston a driving rod which is guided and supported by the inner wall of the barrel and therefore can adapt to all deviations from the ideal shape and in geometry.
- a further advantage is the absence of the problems with connecting tubings between a syringe pump and the cannula penetrating the skin.
- the device according to the invention has almost no dead volume thus avoiding complicated mechanisms to move air out of the system during filling of the pump with injection fluid.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Optics & Photonics (AREA)
- Physiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Manufacturing & Machinery (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Description
- The present invention is related with a device for subcutaneous injection according to the preamble of
claim 1. - One major field of application for this type of device is the injection of physiologically active fluid into a patient and/or the extraction of body fluid for diagnostic purposes. For this use the devices are usually equipped with both a contact surface for attaching to a patient's skin and a cannula for the access to the patient's tissue or vessels for introducing an injection fluid or the removal of analysis fluid.
- Injection devices are widely used in patient care but their size and complexity largely restricts their use to specialized facilities. Recently, ambulatory use of injection devices has been pioneered in diabetes care for the delivery of insulin.
- More recently, because of these drawbacks, infusion devices which can be attached directly to the skin, preferably without long barrels connecting to the subcutaneous delivery cannula are being developed. Due to the necessary reduction in size and weight the precise syringe-type pumps with sufficient volume of injection fluid are difficult to use attached directly to the skin. Therefore, alternative pump types with considerable drawbacks in precision and reliability of delivery under the highly variable environmental and physiologic conditions encountered during real-life operation have been incorporated, e.g. delivery from a reservoir with peristaltic pumps, with piston pumps using valves, or by squeezing a flexible container.
- Wearable drug delivery devices with needles or cannulas and base or bottom members provided with adhesive layers for attachment to a patient's skin are known. For protection of the cannulas prior to and after use the base members are shaped such that they project beyond the cannula tips. For drug delivery the devices are attached to patients and the cannulas are inserted into the skin.
- Document
US 5,931,814 discloses a dermally affixed injection device with a base plate in the form of a cup spring which is provided with an annular adhesive layer for attachment to a patient. Prior to use the base plate is bent to a prestressed shape in which it projects beyond the cannula tip for protecting the cannula. When the spring is released it snaps into its flat position to allow the skin to move towards the cannula. -
US 2004/0116865 discloses a wearable drug infusion device with a base plate provided with an adhesive layer. The base plate has the form of a bistable disc member having a convex and a concave shape. Prior to use the disc member is in its convex shape to protect the needle. To attach the device to a patient and insert the needle the device is manually pressed onto the skin, thereby causing the bistable disc to snap to its concave shape and the needle to be pressed into the skin. -
US 2002/0022798 discloses a wearable drug infusion device with a collapsible bottom cover which prior to use projects beyond the height of the needle. For insertion of the needle into a patient's skin the device is manually pressed onto the skin so that the bottom cover collapses and the needle is pressed into the skin. - 2. Syringe pumps for such applications have barrels with a wide diameter in order to avoid an extended longitudinal footprint, but this solution has disadvantages necessitating high driving forces to inject against a considerable tissue back-pressure and most importantly because of the risk of air bubbles entering and occluding the injection cannula due to almost unavoidable relatively large dead-volumes, and unintended, relatively large bolus injections due to stick-slip effects.
- In this context is known from
US 5,931,814 a dermally affixed injection device with a cannula which prior to use is protected by a base plate being in a prestessed position and after release taking a flat position to allow the skin to move against the cannula. This device, however, cannot be used for patients having a skin with low elasticity. - Several solutions have been suggested for actively pulling the skin towards the cannula.
US 2004/0116865 discloses a needle insertion device with a rigid base plate which is adhesively attached to the skin and has a central portion which upon pressure onto the casing snaps inwards and pulls a small region of the skin towards the needle.US 2002/022798 discloses a fluid delivery device with a needle which is pressed into the skin by turning a selector knob.US 6,186,982 discloses a drug delivery device in which by pressing the casing with a needle towards a hinged base plate whereby the needle pierces the skin.US 4,393,870 discloses an injection device with which the patient's skin is sucked against a cannula by use of a vacuum. None of the disclosed insertion mechanisms fulfills all the desired requirements, such as painless skin piercing, compatibility with patch-type devices or reliability of skin piercing. - The aim of the present invention is to provide an injection device with an improved insertion method which avoids the disadvantages of the state of the art devices.
- According to the invention this is achieved by the characterising features of
claim 1. - The device has a contact surface for contacting a patient's skin or an intravenous port. Typically, the contact surface to the skin is coated with an adhesive and the syringe pump is linked to a cannula having a tip which is configured and dimensioned for piercing the patient's skin or a septum of a port and introducing an injection fluid into the patient or removing analysis fluid.
- In preferred embodiments, the inventive device has a cannula which is fixedly positioned relative to a casing and to the syringe pump. The insertion mechanism of the cannula into the patient's skin comprises preferably a flexible contact surface adhering to the skin.
- When used herein, the following definitions define the stated term
- Adhesive contact surface for temporary wearing on the skin is made of materials with strong adhesive properties, stretchability and minimal allergenicity. This adhesive layer is fixed on the base of the device either covering the entire surface or at least its central part leaving a free rim in such a way that it does not interfere with its flexibility. Preferentially the surface of the adhesive layer which is fixed to the skin is significantly larger than its surface which is fixed to the flexible base of the device, leaving a rim which is not fixed to the flexible base. This can be accomplished e.g. by an adhesive layer extending beyond the surface of the base of the device or, preferentially by using a shape for the adhesive surface to the skin similar to or only slightly larger than the surface of the flexible surface of the device but fixing it to the latter in such a way that an outer annular zone is not fixed to the base of the device. Such a design is described in
EP0825882 for a medical device with a rigid base. - Analysis fluid is blood, interstitial fluid or dialysate having been in contact with interstitial fluid through a semi-permeable membrane.
- Analyte means any endogenous or exogenous substance the concentration of which can be used to diagnose the health, organ function, metabolic status, or drug metabolizing capacity of an individual. Examples of endogenous substances are glucose, lactate, oxygen, creatinine, etc. Examples of exogenous substances are drugs, metabolites of such drugs, diagnostic substances (e.g. inulin) etc.
- Component with a flexible surface is made up of a casing which has preferentially a circular or oval footprint and which has a flexible base. This base plate is constructed in such a way that it can be deformed to a convex shape with a protruding part e.g. like a cone or a gable (position 1). An additional feature of this base is that it can shoot from the convex shape into a flat shape (position 2) with sufficient velocity and force that this movement can provide the driving energy for implantation of the implantable parts of injection cannulas or diagnostic probes by pulling the skin attached by the adhesive surface against the tip of the cannulas or diagnostic probes. Such a flexible surface can be achieved by appropriate segmentation of the surface with hinge regions acting as springs and/or by using elastic materials with the necessary reversible stretching characteristics which moves e.g. from a pre-stressed shape to adopt a flat, relaxed shape.
- Means to position the flexible surface relative to the the implantable parts of injection cannulas or diagnostic probes in two defined positions consists of elements which can bring about the deformation of the flexible surface to a convex, pre-stressed shape and allow a rapid release from this position to adopt a flat, relaxed shape in a coordinated way for the entire surface. This can be accomplished preferentially by several pin-shaped elements protruding from the flexible surface and pushing onto a sliding bolt mechanism, but other constructions using screws, ramps, levers etc. are also possible.
- Such a component with a flexible surface can be manufactured by injection molding of suitable plastics but also by using other materials like steel, composite or ceramic materials, etc. The base of this element has an opening in form of a hole or slit, as opening for the implantable parts of injection cannulas or diagnostic probes. The implantable parts of injection cannulas or diagnostic probes are positioned axially to this base in such a way that in
position 1 they are entirely covered up, whereas inposition 2 they protrude the base. - Delivery of injection fluid encompasses both relatively fast injection (bolus) and relatively slow introduction (also called infusion or instillation) of a liquid into the body.
- Diagnostic probe is the functional element for the determination of analyte concentrations and means, but is not restricted to, any analysis fluid removal and on-line analysis or sampling system. In case of a micro-dialysis system a dialysis membrane forms the interface between the interstitial fluid and a dialysis fluid which is passed at the other side of the membrane. In a preferred embodiment a micro-dialysis probe consists of an outer and an inner barrel, covered at the implantable tip by a dialysis membrane. The inner barrel is connected to the pump which delivers the dialysis fluid and the outer barrel is connected to an analysis or sampling system.
- Functional package is designed to hold the rigid part of the device by a releasable coupling mechanism and has a removable cap to protect the active surface of the diagnostic probes during storage in a defined environment, such as humidity and allows maintaining sterility. The functional package has also a rim element allowing, after removal of the cap, the correct attachment of the rim of the adhesive layer by pressing against the skin. Further, the functional package protects the release/start mechanism of the device against premature, unintended operation and the release/start mechanism can be actuated only following attachment of the device to the skin and removal of the functional package.
- Intravenous port comprises a catheter placed into a vein and having a connective element, preferably a septum at the exterior end of the catheter.
- Sampling means is the functional element for collecting samples of analysis fluid for determination of analytes external to the device by, but not limited to biochemical, immunological, HPLC, or LC/MS/MS methods. The samples can be collected in separated receptacles or in a continuous cavity, e.g. a barrel or tube taking precautions that mixing of samples taken at different times is reduced to a minimum. This can be achieved e.g. by introduction of segments of air or of a non-miscible fluid into the analysis fluid creating separated samples in the continuous cavity.
- Sliding bolt mechanisms adapts upon a circular or linear movement consecutively several fixed positions and consists of elements which display a closed or open state, for example a solid surface or a hole. The movement of the slide mechanism is driven manually or for example by a spring actuated by a release element, for example through pressing or releasing a button or handle, or through a turning movement. For inserting in parallel a fluid delivery cannula and a flexible sensor within a guide needle into the skin by means of a component with a flexible surface attached to the skin, movement of the sliding bolt mechanism from the storage position (position 1) to the next position (position 2) upon an easy manipulation actuates a rapid release of the flexible surface from a pre-stressed shape to adopt a flat, relaxed shape and inserts the fluid delivery cannula and the sensor guide needle into the skin. The interim blockage of the sliding bolt mechanism at
position 2 is now released and allows to actuate the movement of the sliding bolt mechanism to the next position (position 3), which actuates the partial retraction of the guide needle. - In the following preferred embodiments of the invention are described with reference to the accompanying drawings in which
- Fig. 1
- is a diagrammatic sectional top view of an injection device with a circular syringe pump showing the principle of a circular syringe pump according to state of the art construction but with an improved solution allowing a limited adaptation of the piston to the curvature of the barrel.
- Fig. 2
- is a diagrammatic cross sectional view of a syringe filling and an injection cannula insertion mechanism into the skin according to one embodiment of the invention.
- The injection device shown in
Fig. 1 has a casing having a cylindrical side-wall 1 housing a barrel in form of a segment of atoroidal tube 2. Oneend 3 of the barrel is provided with a connecting channel to a cannula (not shown). The barrel has a circular cross section. - A
piston 4 is arranged in the interior of the barrel and is provided with a seal fitting tightly at the inner wall of the barrel. The piston is connected to a drivingrod 6 which is circularly shaped for driving the piston through the entire length of the barrel. - Using established technologies for manufacturing of a toroidal cylinder the fit between its curvature and the driving rod of the piston will not be perfect. To correct for this the
mechanism 5 disclosed here connecting the piston to therod 6 allowing radial adaptation of the piston represents an improvement as compared to the state of the art solutions e.g. as described by M.P. Loeb and A.M. Olson inUS patent 4,525,164 , using a resilient spherical piston which is slidably contacted by a cupped distal end of a driving stem allowing it to rotate within the barrel, since such a construction has intrinsic problems of sealing and friction. - At its end opposite the piston the driving rod has a perpendicularly
bent arm 7 extending to a central pivot, thereby reducing the radial component of the force and the resulting friction by moving the piston through the barrel. The inner side of the rod has agear rim 8 which is driven by agear drive 9. The gear drive is driven e.g. by a gear train and an electrical motor (for example a watchwork drive) which can be regulated for controlled delivery by signals from inbuilt and/or remote control elements (not shown in the figure). Alternatively, other drives, as known in prior art, can be employed. - Using standard manufacturing technologies for the toroidal barrel such as e.g. plastics-technologies with an injection molding tool having a mandrel which has to be removed by a rotary motion, deviations from a perfect circular shape and variations in its shape are unavoidable due to inherent differences in shrinkage e.g. of the proximal and distal part of the torus wall during manufacturing. Because of this almost unavoidable deviation from an ideal circular shape for the manufactured torus the exact geometric fit between the barrel and the driving rod of the piston moved by a rotary motion can not be secured. Even if the driving rod of the piston is manufactured using steel-technologies with a high level of form-stability, the fit of the attached piston to the barrel's shape along its longitudinal axis becomes variable. Indeed, e.g. a difference of only 2% between the radius of the barrel and of the driving rod causes a serious relative shift which can lead to collision between barrel wall and driving rod for torus arcs of e.g. 150° - 160° which can be manufactured with standard technologies and are aimed at in order to sufficiently reduce the footprint of the syringe-type pump. In addition, the plastics parts usually used to manufacture the housing holding the barrel and the guideways for the driving rod are not absolutely rigid and can slightly deform especially under the applied forces necessary to provide the pressures of several bar to overcome tissue resistance. The resulting radial and axial forces to correct for the actual shape differences between axis of barrel and driving rod can become very substantial with a rigid driving rod which is used for arcuate piston-drive mechanisms described so far. These forces have to be absorbed by the sealing of the piston leading to its deformation causing high friction with resulting stick-slip phenomena up to blockage and/or problems with tightness of the piston. Even if the piston can adapt slightly to correct for the deviation between the axis of the barrel and of the driving rod as described in prior art and with the improvement discussed and exemplified in
Fig. 1 the worst case scenario of blockage by clamping between the rigid driving rod and the barrel wall cannot be excluded. Therefore, for medical use of controlled and precise fluid delivery constructions according to prior art in which a driving mechanism with a rigid driving rod is used to move the piston in an arcuate barrel are not sufficiently safe. These problems get even more pronounced at low barrel diameters required for syringe-type pumps intended for the precise delivery of small volumes such as e.g. insulin for diabetic patients. - According to the subject invention, the solution to avoid stick-slip phenomena and/or problems with tightness or even blockage of the piston or clamping between the rigid driving rod and the barrel wall is to use a driving rod of the piston which adapts to the actual curvature of the barrel, being guided and supported by the inner wall of the barrel. In contrast to constructions described in prior art the rod guided and supported by the inner wall of the barrel of the subject invention can adapt to all deviations from the ideal shape and geometry which are unavoidable using cost-effective manufacturing technologies and materials. A preferred embodiment of the subject invention, which can be adapted for both, fluid delivery and fluid withdrawal, is exemplified in
Fig 2 . -
Fig. 2 is the central part of a tangential cut of the device through theend portion 3 of the barrel. Afirst channel 15 is leading to the upper side of the device and is closed by aseptum 14. For filling the barrel with injection fluid a syringe (not shown) having aneedle 13 is pierced through theseptum 14. Before filling, the piston is touching theend portion 3 of the barrel (not shown). The injection fluid is introduced throughchannel 15, thereby pushing the piston towards the opposite end of the barrel. - A
second channel 17 is leading from the interior ofbarrel 2 to aninjection cannula 16 for delivery of injection fluid into the skin. Thecannula 16 is closed at the other end with a septum-seal 18 which is held in ahousing 19. The overall construction is such that the dead volume is minimal and no significant volume of air is in the system after filling with injection fluid. - In the exemplified embodiment the insertion means into the skin of the
cannula 16 has aflexible base plate 20 which is attached to the skin by anadhesive layer 21. In the ready-to-use mode shown in the figure this flexible base plate is deformed to a convex shape covering thecannula 16. The base plate is preferentially annular or oval and in order to insert a cannula which is remote from the center of the device consists preferentially of two segments with a diagonal slit, forming a gable upon bending. This configuration allows also to use this insertion means for more than one cannula simultaneously which are positioned along the diagonal slit, e.g. if more than one infusion pumps for more than one infusion fluid is used and/or for the combination with insertion of a diagnostic probe into the skin. - By the spring-type mechanism, in addition the septum-
seal 18 is pierced by the cannula before it enters the skin. The segments are attached to the circumference of thecasing 1 by springy hinge regions and are in addition preferentially made of a flexible material. Alternative forms like a radial segmentation, preferably into 5 to 8 segments with a spacing between them and a central opening, forming a cone upon central bending are also possible if the cannula is placed close to the center of the device. - On its underside, the flexible base plate has an annular or oval adhesive layer for securing the device to the patient's skin with a diagonal slit or a concentric central opening, respectively similar to the base plate. This adhesive layer is composed of three parts, a glue for fixing to the flexible base plate, a textile providing the necessary flexibility and a glue for fixing onto the skin. Suitable materials with low allergenicity potential are commercially available. The adhesive layer can have a larger circumference than the device but it could have also the same circumference if the attachment to the base plate leaves an outer zone where it is not connected to the housing.
- Upon release of the pre-stressed base plate actuated e.g. by a sliding bolt mechanism (not shown) it rapidly relaxes to a flat shape towards the bottom of the housing of the
device 1, pushes thehousing 19 of the septum-seal 18, and thecannula 16 pierces through the septum-seal 18 and through the skin attached by the adhesive layer. - Upon reading this specification, various alternative embodiments will become obvious to the skilled artisan. For example, the drive means for moving the piston or the implantation mechanism of the cannula for delivery of injection fluid into a patient, or for removal of analysis fluid of a patient could be achieved via numerous chemical, mechanical, or electrical means. Further, a large variety of diagnostic elements for the online analysis or for sampling of analysis fluid for removed analysis as well as control and measuring means can be accommodated with the device.
- The major advantages of a device with a toroidal syringe-type pump described above are its reduced footprint-size by which it can be comfortably worn and operated by the patient and at the same time the inherent high precision of a syringe type pump. The intrinsic problems of such pumps exemplified in prior art of sealing, friction causing stick-slip phenomena, and even blockage caused by lack of exact fit between the actual form of the arcuate barrel and of the plunger unavoidable in manufacturing of the toroidal barrel and the device using standard cost-effective technologies are solved by using as the drive for the piston a driving rod which is guided and supported by the inner wall of the barrel and therefore can adapt to all deviations from the ideal shape and in geometry. A further advantage is the absence of the problems with connecting tubings between a syringe pump and the cannula penetrating the skin. In addition, the device according to the invention has almost no dead volume thus avoiding complicated mechanisms to move air out of the system during filling of the pump with injection fluid.
Claims (3)
- Device for subcutaneous injection of fluid into a patient's skin comprising- a casing which houses- a pump (2,4),- a cannula (16) having a tip for being inserted into the patient's skin, the cannula being fixedly positioned relative to the pump,- means for inserting the cannula into the patient's skin,- a flexible base plate (20) being fixed to the casing and having a prestressed convex position in which the tip of the cannula is concealed and a released flat position in which the tip of the cannula is exposed beyond the base plate,- a mechanism comprising means for holding the base plate in the prestressed convex position and for releasing the base plate to move from its prestressed position to its released flat position,- characterized by- an adhesive layer (21) fixed to the flexible base plate and covering at least the central part of the base plate for adhering the base plate onto the patient's skin, whereby when moving from the prestressed convex position to the released flat position the base plate is pulling the adhered skin against the tip of the cannula.
- Device according to claim 1, characterized in that the means for bringing the flexible base plate from a first to a second position makes use of the elasticity of this base plate for a rapid movement by relaxation from an enforced tense position.
- Device according to claim 1, characterized in that the means for bringing the flexible base plate into two distinct positions comprises a sliding bolt mechanism actuated by pressing a knob.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10187141A EP2438938A1 (en) | 2010-10-11 | 2010-10-11 | Syringe type pump |
PCT/EP2011/067535 WO2012049080A2 (en) | 2010-10-11 | 2011-10-07 | Syringe type pump |
EP11767246.9A EP2627374B1 (en) | 2010-10-11 | 2011-10-07 | Syringe type pump |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11767246.9A Division EP2627374B1 (en) | 2010-10-11 | 2011-10-07 | Syringe type pump |
EP11767246.9A Division-Into EP2627374B1 (en) | 2010-10-11 | 2011-10-07 | Syringe type pump |
Publications (4)
Publication Number | Publication Date |
---|---|
EP2907535A2 EP2907535A2 (en) | 2015-08-19 |
EP2907535A3 EP2907535A3 (en) | 2015-11-25 |
EP2907535B1 true EP2907535B1 (en) | 2024-02-07 |
EP2907535C0 EP2907535C0 (en) | 2024-02-07 |
Family
ID=43533199
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10187141A Withdrawn EP2438938A1 (en) | 2010-10-11 | 2010-10-11 | Syringe type pump |
EP15154808.8A Active EP2907535B1 (en) | 2010-10-11 | 2011-10-07 | Syringe type pump |
EP11767246.9A Active EP2627374B1 (en) | 2010-10-11 | 2011-10-07 | Syringe type pump |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10187141A Withdrawn EP2438938A1 (en) | 2010-10-11 | 2010-10-11 | Syringe type pump |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP11767246.9A Active EP2627374B1 (en) | 2010-10-11 | 2011-10-07 | Syringe type pump |
Country Status (9)
Country | Link |
---|---|
US (2) | US10130756B2 (en) |
EP (3) | EP2438938A1 (en) |
JP (4) | JP2014502855A (en) |
CN (2) | CN103313741B (en) |
CA (2) | CA2895617C (en) |
DK (1) | DK2627374T3 (en) |
ES (2) | ES2970794T3 (en) |
HK (2) | HK1184403A1 (en) |
WO (1) | WO2012049080A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2650032A1 (en) * | 2012-04-11 | 2013-10-16 | PharmaSens AG | Subcutaneous needle insertion mechanism |
EP2679154A1 (en) | 2012-06-25 | 2014-01-01 | PharmaSens AG | Sub-epidermal electric warning device |
EP2879741B1 (en) | 2012-07-31 | 2021-04-28 | Nipro Healthcare Systems, LLC | Device and method for dispensing fluid from an infusion pump |
US20150217058A1 (en) | 2012-09-24 | 2015-08-06 | Enable Injections, Llc | Medical vial and injector assemblies and methods of use |
EP2716315A1 (en) * | 2012-10-08 | 2014-04-09 | IN. Medica, d.o.o. | Precision liquid dispensing device |
BR112015008224A2 (en) * | 2012-10-16 | 2017-07-04 | Swissinnov Product Sarl | fluid release device for releasing small amounts of fluid to a patient, system for releasing small amounts of fluid for a patient, detachable adjustable bifunctional connector on the fluid release device and method for installing the fluid release device in a patient |
DK3010568T3 (en) | 2013-06-18 | 2019-05-06 | Enable Injections Inc | Device for transfer with vial and injection |
EP2842586A1 (en) * | 2013-08-27 | 2015-03-04 | PharmaSens AG | Device with a lavet-type motor |
KR20160084404A (en) * | 2013-10-31 | 2016-07-13 | 스위스인노브 프로덕트 에스에이알엘 | Portable pump and method for producing same |
KR101615745B1 (en) | 2014-08-20 | 2016-04-26 | 서울대학교 산학협력단 | Drug infusion pump including stackable curved syringe |
US20160051755A1 (en) * | 2014-08-25 | 2016-02-25 | Medtronic Minimed, Inc. | Low cost fluid delivery device |
US20180207369A1 (en) * | 2017-01-23 | 2018-07-26 | Enable Injections, Inc. | Medical fluid injection device with fill indicator |
CN108844571B (en) * | 2018-07-16 | 2024-08-30 | 河北农业大学 | Online calibration device and method for poultry house harmful gas sensor |
CN116983506A (en) | 2019-02-22 | 2023-11-03 | 德卡产品有限公司 | Infusion set and insert assembly systems and methods |
US11324881B2 (en) * | 2019-11-21 | 2022-05-10 | Medtronic Minimed, Inc. | Systems for wearable infusion port and associated pump |
CN113499508B (en) * | 2021-07-14 | 2022-08-26 | 巨翊科技(上海)有限公司 | Infusion pump capable of automatically clamping and infusing tube |
US12114843B2 (en) | 2022-03-31 | 2024-10-15 | Ethicon, Inc. | Sealant applicators having mixing and spraying assemblies with malleable sections and spray tips having reduced dimensions |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT280218B (en) * | 1965-04-07 | 1970-04-10 | Ceskoslovenska Akademie Ved | Method and device for reducing subsequent mixing of already separated components |
US4393870A (en) * | 1974-11-19 | 1983-07-19 | Wolfgang Wagner | Suction injector |
US4525164A (en) * | 1981-04-24 | 1985-06-25 | Biotek, Inc. | Wearable medication infusion system with arcuated reservoir |
AT384737B (en) * | 1986-04-04 | 1987-12-28 | Thoma Dipl Ing Dr Techn Herwig | DEVICE FOR CONTINUOUSLY DELIVERING LIQUID MEDICINAL PRODUCTS |
US4886499A (en) * | 1986-12-18 | 1989-12-12 | Hoffmann-La Roche Inc. | Portable injection appliance |
CA2159052C (en) * | 1994-10-28 | 2007-03-06 | Rainer Alex | Injection device |
AU5895196A (en) * | 1995-05-22 | 1996-12-11 | F. Hoffmann-La Roche Ag | Medical device adhering to the skin |
US6149604A (en) * | 1995-09-07 | 2000-11-21 | Kosasky; Harold J. | Instrument for measuring saliva viscoelasticity to determine female fertile period |
HUP9904152A3 (en) * | 1996-07-05 | 2000-05-29 | Novo Nordisk As | Flexible piston rod |
US6607509B2 (en) * | 1997-12-31 | 2003-08-19 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US6186982B1 (en) * | 1998-05-05 | 2001-02-13 | Elan Corporation, Plc | Subcutaneous drug delivery device with improved filling system |
US6530900B1 (en) * | 1997-05-06 | 2003-03-11 | Elan Pharma International Limited | Drug delivery device |
ATE324922T1 (en) * | 1999-06-08 | 2006-06-15 | Altea Therapeutics Corp | DEVICE FOR MICROPORATION OF A BIOLOGICAL TISSUE USING A FILM TISSUE INTERFACE DEVICE AND METHOD |
US6585699B2 (en) * | 2000-04-13 | 2003-07-01 | Nna/S | Drug delivery device provided with a one-way mechanism |
US6589229B1 (en) * | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
CA2420048C (en) * | 2000-08-18 | 2009-10-27 | Becton, Dickinson And Company | Constant rate fluid delivery device with selectable flow rate and titratable bolus button |
US6537251B2 (en) * | 2000-10-05 | 2003-03-25 | Novo Nordisk A/S | Medication delivery device with bended piston rod |
US8784335B2 (en) * | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
ATE431168T1 (en) * | 2002-10-07 | 2009-05-15 | Novo Nordisk As | NEEDLE INSERTION DEVICE |
US7014625B2 (en) * | 2002-10-07 | 2006-03-21 | Novo Nordick A/S | Needle insertion device |
JP4522364B2 (en) * | 2002-11-01 | 2010-08-11 | ペリカン テクノロジーズ インコーポレイテッド | Body fluid sampling device |
US20080119703A1 (en) * | 2006-10-04 | 2008-05-22 | Mark Brister | Analyte sensor |
GB0420062D0 (en) * | 2004-09-09 | 2004-10-13 | Akubio Ltd | Assay methods,materials and preparations |
US9259175B2 (en) * | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9233203B2 (en) * | 2005-05-06 | 2016-01-12 | Medtronic Minimed, Inc. | Medical needles for damping motion |
US8137314B2 (en) * | 2006-08-23 | 2012-03-20 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with compressible or curved reservoir or conduit |
DE202006004748U1 (en) * | 2005-12-13 | 2007-04-26 | Trw Automotive Gmbh | Belt tensioner for a safety belt system |
US8114064B2 (en) * | 2006-03-16 | 2012-02-14 | Calibra Medical, Inc. | Infusion device with piston pump |
JP2009539444A (en) * | 2006-06-06 | 2009-11-19 | ノボ・ノルデイスク・エー/エス | An assembly comprising a device attachable to the skin and a package of the device |
DK2121076T3 (en) * | 2006-12-29 | 2017-07-24 | Hoffmann La Roche | Infusion device that can be worn outside the body |
US20100137802A1 (en) * | 2007-05-11 | 2010-06-03 | Ofer Yodfat | Methods and appratus for monitoring rotation of an infusion pump driving mechanism |
WO2009016636A2 (en) * | 2007-08-01 | 2009-02-05 | Medingo Ltd. | Portable infusion device provided with means for monitoring and controlling fluid delivery |
ES2688062T3 (en) * | 2009-01-12 | 2018-10-30 | Becton, Dickinson And Company | Infusion set and / or patch pump having at least one of a rigid internal permanence catheter with flexible features and / or a flexible catheter connection |
-
2010
- 2010-10-11 EP EP10187141A patent/EP2438938A1/en not_active Withdrawn
-
2011
- 2011-10-07 DK DK11767246.9T patent/DK2627374T3/en active
- 2011-10-07 CN CN201180049140.2A patent/CN103313741B/en active Active
- 2011-10-07 WO PCT/EP2011/067535 patent/WO2012049080A2/en active Application Filing
- 2011-10-07 EP EP15154808.8A patent/EP2907535B1/en active Active
- 2011-10-07 CA CA2895617A patent/CA2895617C/en active Active
- 2011-10-07 EP EP11767246.9A patent/EP2627374B1/en active Active
- 2011-10-07 JP JP2013533159A patent/JP2014502855A/en active Pending
- 2011-10-07 ES ES15154808T patent/ES2970794T3/en active Active
- 2011-10-07 US US13/878,569 patent/US10130756B2/en active Active
- 2011-10-07 ES ES11767246.9T patent/ES2671244T3/en active Active
- 2011-10-07 CA CA2813525A patent/CA2813525C/en active Active
- 2011-10-07 CN CN201510344617.XA patent/CN105126194B/en active Active
-
2013
- 2013-10-24 HK HK13111986.8A patent/HK1184403A1/en unknown
-
2015
- 2015-06-15 US US14/738,995 patent/US10117989B2/en active Active
- 2015-08-11 JP JP2015159098A patent/JP6490534B2/en active Active
-
2016
- 2016-01-29 HK HK16101069.6A patent/HK1213207A1/en unknown
- 2016-06-16 JP JP2016120214A patent/JP6434454B2/en active Active
-
2017
- 2017-05-08 JP JP2017092697A patent/JP6423916B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2970794T3 (en) | 2024-05-30 |
EP2907535A3 (en) | 2015-11-25 |
US20130324884A1 (en) | 2013-12-05 |
CA2813525A1 (en) | 2012-04-19 |
CN103313741A (en) | 2013-09-18 |
JP2015231560A (en) | 2015-12-24 |
US20150273139A1 (en) | 2015-10-01 |
JP6490534B2 (en) | 2019-03-27 |
EP2627374A2 (en) | 2013-08-21 |
US10130756B2 (en) | 2018-11-20 |
CA2895617A1 (en) | 2012-04-19 |
CN105126194B (en) | 2019-05-17 |
CN105126194A (en) | 2015-12-09 |
CA2895617C (en) | 2020-12-29 |
JP6434454B2 (en) | 2018-12-05 |
CN103313741B (en) | 2015-07-15 |
JP2016190058A (en) | 2016-11-10 |
EP2907535C0 (en) | 2024-02-07 |
DK2627374T3 (en) | 2018-06-14 |
JP2017148596A (en) | 2017-08-31 |
HK1184403A1 (en) | 2014-01-24 |
JP2014502855A (en) | 2014-02-06 |
HK1213207A1 (en) | 2016-06-30 |
CA2813525C (en) | 2019-01-15 |
EP2438938A1 (en) | 2012-04-11 |
WO2012049080A3 (en) | 2012-06-28 |
EP2627374B1 (en) | 2018-02-28 |
WO2012049080A2 (en) | 2012-04-19 |
ES2671244T3 (en) | 2018-06-05 |
EP2907535A2 (en) | 2015-08-19 |
JP6423916B2 (en) | 2018-11-14 |
US10117989B2 (en) | 2018-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2907535B1 (en) | Syringe type pump | |
EP2836255B1 (en) | Subcutaneous needle insertion mechanism | |
US7981085B2 (en) | Internal needle inserter | |
EP2836254B1 (en) | Manual pressure activated application mechanism | |
JP6893436B2 (en) | Percutaneous wearing device for vein access |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2627374 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61M 5/158 20060101AFI20151021BHEP Ipc: A61M 5/32 20060101ALI20151021BHEP Ipc: A61M 5/142 20060101ALI20151021BHEP Ipc: A61B 5/15 20060101ALI20151021BHEP Ipc: A61M 5/31 20060101ALI20151021BHEP Ipc: A61M 5/172 20060101ALI20151021BHEP Ipc: A61M 5/315 20060101ALI20151021BHEP Ipc: A61M 5/145 20060101ALI20151021BHEP |
|
17P | Request for examination filed |
Effective date: 20160525 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20190409 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20231121 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AC | Divisional application: reference to earlier application |
Ref document number: 2627374 Country of ref document: EP Kind code of ref document: P |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602011074565 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
U01 | Request for unitary effect filed |
Effective date: 20240207 |
|
U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20240213 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2970794 Country of ref document: ES Kind code of ref document: T3 Effective date: 20240530 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240607 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240207 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240507 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240507 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240507 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240607 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240207 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240508 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240207 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20240207 |